Use of estrogen antagonists and estrogen agonists in...

Details Use of estrogen antagonists and estrogen agonists in... Use of estrogen antagonists and estrogen agonists in...

A - Human Necessities

61

K

A61K 31/395 (2006.01) A61K 31/40 (2006.01) A61K 31/4439 (2006.01) A61K 31/4453 (2006.01) A61K 31/4725 (2006.01)

Patent

CA 2198578

Disclosed is a pharmaceutical composition for inhibiting pathological conditions related to organ systems which respond to estrogen agonists in a mammal. The composition comprises an effective amount of a compound of formula I (see fig.I) (wherein A is CH2 or NR; R is H or alkyl; B, E and D are each CH or N; Y is a cyclic group such as phenyl; Z1 is a divalent group such as -OCH2CH2-; G is an optionally substituted amino such as piperidino or pyrrolidino; and e is 0, 1 or 2).

Composition pharmaceutique pour traiter les troubles biologiques liés à des systèmes organiques qui réagissent à des agonistes de l'oestrogène chez les mammifères. La composition renferme une quantité efficace d'un composé de formule I (voir fig. I) ¢où A est CH2 ou NR; R est H ou un alkyle; B, D et E sont chacun CH ou N; Y est un groupe cyclique comme le phényle; Z1 est un groupe divalent comme -OCH2CH2; G est un groupe amino avec substitution facultative, comme un pipéridino ou un pyrrolidino; e est 0, 1 ou 2!.

Affiliated with

Also associated with

Rating

Use of estrogen antagonists and estrogen agonists in... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of estrogen antagonists and estrogen agonists in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of estrogen antagonists and estrogen agonists in... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1656353